• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS MESH SOFRADIM - UGYTEX¿; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS MESH SOFRADIM - UGYTEX¿; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number UGYKA
Device Problems Material Protrusion/Extrusion (2979); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Micturition Urgency (1871); Irritation (1941); Urinary Frequency (2275); Injury (2348); Irritability (2421); Tissue Breakdown (2681)
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient's attorney alleged a deficiency against the device resulting in an unspecified outcome.Product was used for therapeutic treatment.The mesh was implanted as the patient had stress urinary incontinence (sui), rectal dysfunction, cystocele and enterocele.The procedure (s) performed were anterior and posterior mesh placement, mid urethral sling placement, enterocele ablation and cystoscopy.Postoperative complications patient experienced were - in 2007 -urinary frequency, urgency, post void dribbling, bladder irritability, mid urethral sling that was visible through the vaginal mucosa and possibly either a wound breakdown at that site or possibly a rejection - pelvic shows the anterior vagina, there is a mid urethral sling which is being extruded through the submucosa, the mid urethral sling which is being extruded at this time in an area of approximately 10-12 mm by approximately 3 mm ¿ plan for mid urethral sling revision and cystoscopy.Patient had mesh revision surgery (uretex to2) in 2007 - underwent resection of mid urethral sling for extrusion under general anesthesia (interim medical records from 01/23/2007 to 04/08/2014 pertaining to tvm is not available to know the clinical condition of the patient).Following the mesh revision surgery, she developed complications that required additional surgery.Complications includes urinary incontinence, mesh exposure in left anterior fornix of the vagina just behind the pubic bone during 2007 ¿2014 for which she had undergone the following additional surgeries.Additional mesh (uretex to2) revision surgery in 2014 where patient had underwent excision of exposed vaginal mesh for vaginal mesh exposure under general anesthesia (further medical records are not available for review).
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MESH SOFRADIM - UGYTEX¿
Type of Device
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
Manufacturer (Section G)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR   01600
Manufacturer Contact
lisa hernandez
60 middletown ave
north haven, CT 06473
2034925563
MDR Report Key7739388
MDR Text Key115700677
Report Number9615742-2018-01777
Device Sequence Number1
Product Code FTL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K050187
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 10/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUGYKA
Device Catalogue NumberUGYKA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/05/2015
Initial Date FDA Received08/01/2018
Supplement Dates Manufacturer Received08/08/2018
Supplement Dates FDA Received10/03/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age50 YR
-
-